Design, synthesis and molecular docking studies of S- alkylated thiadiazole derivatives containing phthalimide moiety as antimicrobial agents

Year 2025, Volume: 29 Issue: 4, 1573 - 1581, 05.07.2025

Farshid Hassanzadeh , Elham Jafari , Monire Nicoobin Vajihe Akbari

https://doi.org/10.12991/jrespharm.1734633

Abstract

Considering the incidence of infectious diseases and emergence of antibiotic-resistance bacterial and
fungal strains, the discovery of new antimicrobial agents is essential. Thiadiazole as an useful pharmacophore is
considered in drug discovery researches. Reported thiadiazole derivatives with antimicrobial properties indicate the
importance of this scaffold as antimicrobial agent. Compounds bearing phthalimide moiety also have been identified
as antimicrobial agents. The existing work was conducted to evaluate the antimicrobial property of new thiadiazole –
phthalimide hybrid derivatives. Thiadiazole-phthalimide hybrid derivatives were prepared by the reaction of phthalic
anhydride with amine group of various s-alkylated thiadiazole derivatives which followed by evaluation of
antimicrobial properties using tube dilution technique against bacterial and fungal strains. The final molecules were
docked in the active sites of Escherichia coli topoisomerase II DNA gyrase B to assay the possible interactions. Compound
3a was found to be active against Staphylococcus aureus , Escherichia coli and in particular Candida albicans with minimum
inhibitory concentration values of 0.75, 0.18, 0.09 (mg/mL), respectively. None of the compounds had activity against
Pseudomonas aeruginosa in studied concentrations. The highest docking score was -8.41kcal/mol for compound 3b which
can confirm the experimental results.

Keywords

Synthesis , Thiadiazole , Antimicrobial , Topoisomerase , Molecular Docking

References

• Serban G, Stanasel O, Serban E, Bota S. 2-Amino-1, 3, 4-thiadiazole as a potential scaffold for promising antimicrobial agents. Drug Des Devel Ther. 2018, 12: 1545–1566. https://doi.org/10.2147/DDDT.S155958.
• Altıntop MD, Kaplancıklı ZA, Çiftçi GA, Demirel R. Synthesis and biological evaluation of thiazoline derivatives as new antimicrobial and anticancer agents. Eur J Med Chem. 2014, 74: 264-277. https://doi.org/77.10.1016/j.ejmech.2013.12.060.
• Maddila S, Jonnalagadda SB. Synthesis and antimicrobial activity of new 1, 3, 4-thiadiazoles containing oxadiazole, thiadiazole and triazole nuclei. Pharm Chem J. 2013, 46 (11): 661-666. https://doi.org/10.1007/s11094-013-0865-x
• Rad O, Tibor R, Duma M, Vlase L, Pîrnău A, Tiperciuc B, Ionuţ I, OnigaO. Synthesis and antimicrobial activity of some 5-amino-2-mercapto-1, 3, 5-thiadiazole derivatives thioeters and schiff bases. STUDIA UBB CHEMIA. 2016; 61(1): 17-32.
• Tahtaci H, Karacık H, Ece A, Er M, Şeker MG. Design, Synthesis, SAR and Molecular Modeling Studies of Novel Imidazo [2, 1‐b][1, 3, 4] Thiadiazole derivatives as highly potent antimicrobial agents. Mol Inform. 2018, 37(3). https://doi.org/10.1002/minf.201700083.
• Önkol T, Doğruer DS, Uzun L, Adak S, Özkan S, Fethi Şahin M. Synthesis and antimicrobial activity of new 1, 2, 4- triazole and 1,3,4-thiadiazole derivatives. J Enzyme Inhib Med Chem. 2008, 23 (2): 277-284. https://doi.org/10.1080/14756360701408697.
• Asif M. A mini review on pharmacological activities of oxadiazole and thiadiazole compounds. Mor J Chem. 2014, 2 (2): 70-84.
• Parmar KC, Umrigar NH. Review article on synthesis of 1, 3, 4-thiadiazole derivatives and it’s biological activity. J Chem Pharm Res. 2017, 9(6):202-214.
• Othman AA, Kihel M, Amara S. 1,3,4-Oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives as potential antibacterial agents. Arab J Chem. 2019, 12 (7): 1660-1675. https://doi.org/10.1016/j.arabjc.2014.09.003.
• Alegaon SG, Alagawadi KR. Synthesis, characterization and antimicrobial activity evaluation of new imidazo [2,1- b][1,3,4] thiadiazole derivatives. Eur J Chem. 2011, 2(1): 94-99. https://doi.org/10.5155/eurjchem.2.1.94-99.161.
• Jain AK, Sharma S, Vaidya A, Ravichandran V, Agrawal RK. 1,3,4‐Thiadiazole and its derivatives: A review on recent progress in biological activities. Chem Biol Drug Des. 2013, 81(5): 557-576. https://doi.org/10.1111/cbdd.12125.
• Khalilullah HA, Khan MU, Mahmood DA, Akhtar JA, Osman GA. 1,3,4-Thiadiazole: a biologically active scaffold. Int J Pharm Pharm Sci. 2014, 6(9): 8-15.
• Farghaly TA, Abdallah MA, Aziz MR. Synthesis and antimicrobial activity of some new 1,3,4-thiadiazole derivatives. Molecules. 2012; 17(12):14625-14636. https://doi.org/10.3390/molecules171214625.
• Dou L, Shi H, Niu X, Zhang H, Zhang K, Wu Z. Design, synthesis and antifungal mechanism of novel acetophenone derivatives containing 1,3,4-thiadiazole-2-thioethers. New J Chem. 2022; 46 (19): 9017-9023. https://doi.org/10.1039/d2nj01709a.
• Liu D, Wang Z, Zhou JJ, Gan X. Design, synthesis and nematocidal activity of novel 1, 2, 4-oxadiazole derivatives with a 1, 3, 4-thiadiazole amide moiety. Phosphorus, Sulfur, and Silicon and the Related Elements. 2022; 179(9): 934- 942. https://doi.org/10.1080/10426507.2022.2046580.
• Hassanzadeh F, Jafari E, Saeedi M, Saberi S. Synthesis and evaluation of thiadiazole-based antileishmanial agents. J Rep Pharm Sci. 2020; 9 (2):189-195. https://doi.org/10.4103/jrptps.JRPTPS_3_20.
• Radi M, Crespan E, Botta G, Falchi F, Maga G, Manetti F, Corradi V, Mancini M, Santucci MA, Schenone S, Botta M. Discovery and SAR of 1,3,4-thiadiazole derivatives as potent Abl tyrosine kinase inhibitors and cytodifferentiating agents. Bioorg Med Chem Lett. 2008, 18 (3): 1207-1211. https://doi.org/10.1016/j.bmcl.2007.11.112.
• Zhang K, Wang P, Xuan LN, Fu XY, Jing F, Li S, Liu YM, Chen BQ. Synthesis and antitumor activities of novel hybrid molecules containing 1,3,4-oxadiazole and 1,3,4-thiadiazole bearing Schiff base moiety. Bioorg Med Chem Lett. 2014;24(22):5154-5156. https://doi.org/10.1016/j.bmcl.2014.09.086.
• Tang J, Liu J, Wu F. Molecular docking studies and biological evaluation of 1, 3, 4-thiadiazole derivatives bearing Schiff base moieties as tyrosinase inhibitors. Bioorg Chem. 2016; 69: 29-36. https://dx.doi.org/10.1016/j.bioorg.2016.09.007.
• Wassel MM, Ammar YA, Ali GA, Belal A, Mehany AB, Ragab A. Development of adamantane scaffold containing 1, 3, 4-thiadiazole derivatives: Design, synthesis, anti-proliferative activity and molecular docking study targeting EGFR. Bioorg Chem. 2021; 110: 104794. https://doi.org/10.1016/j.bioorg.2021.104794.
• Alwan SM. Synthesis and preliminary antimicrobial activities of new arylideneamino-1,3,4-thiadiazole-(thio/dithio)- acetamido cephalosporanic acids. Molecules. 2012, 17 (1): 1025-1038. https://doi.org/10.3390/molecules17011025.
• Karthik CS, Mallesha L, Mallu P. Investigation of antioxidant properties of phthalimide derivatives. Can Chem Trans. 2015; 3 (2): 199-206. https://doi.org/10.13179/canchemtrans.2015.03.02.0194.
• Hassanzadeh F, Jafari E. Cyclic imide derivatives: As promising scaffold for the synthesis of antimicrobial agents. J Res Med Sci. 2018;23: 1-7. https://doi.org/10.4103/jrms.JRMS_539_17.
• Jafari E. , Taghi jarah-Najafabadi N, Jahanian-Najafabadi A, Poorirani S, Hassanzadeh F, Sadeghian-Rizi S. Synthesis and evaluation of antimicrobial activity of cyclic imides derived from phthalic and succinic anhydrides. Res Pharm Sci. 2017; 12(6): 526-534. https://doi.org/10.4103/1735-5362.217433.
• Patel H, Shirkhedkar A, Bari S, Patil K, Arambhi A, Pardeshi C, Kulkarni A, Surana S. Quinazolino-thiadiazoles as antimicrobial agents. Bull Fac Pharm. 2018, 56 (1): 83-90. https://doi.org/10.1016/j.bfopcu.2018.03.001.
• Durgadasheemi NN, Kolageri SN. Novel 1, 3, 4-Oxadiazole-pyridine hybrids as potential DNA gyrase B inhibitors (5D7R): ADMET prediction and molecular docking study. J Drug Deliv Ther. 2023; 13 (3): 12-19. https://doi.org/10.22270/jddt.v13i3.5749.
• Jakopin Z, Ilaš J, Barančokova M, Brvar M , Tammela P, SollnerDolenc M, Tomašič T, Kikelj, D. Discovery of substituted oxadiazoles as a novel scaffold for DNA gyrase inhibitors. Eur J Med Chem. 2017; 130: 171-184. https://doi.org/10.1016/j.ejmech.2017.02.046.
• Ramalakshmi N, Prabakaran A, Sumithra S., Keerthika S, Nivetha J, Raveena R. Design, synthesis, molecular docking and ınsilico analysis of some novel 2-Amino-1,3,4-Thiadiazole Derivatives as Potent DNA Gyrase B Inhibitors. Curr Bioact Compd. 2021; 17 (7): 1-10. https://doi.org/10.2174/1573407216999201208204054.
• Vaghasiya MD, Mendapara JV, Ahmad I, Patel H, Rajani DP, Kumari P. Development of novel thiazole-based hybrids as DNA gyrase inhibitors: Design, synthesis, in silico and in vitro antibacterial evaluation. J Iran Chem Soc. 2024; 21(19): 1531–1545. https://doi.org/10.1007/s13738-024-03011-z.
• Othman IMM, Gad-Elkareem MAM, El-Naggar M, Nossier ES, El-Galil E. Amr A. Novel phthalimide based analogues: Design,synthesis, biological evaluation, and molecular docking studies. J Enzyme Inhib Med Chem. 2019; 34 (1): 1259-1270. https://doi.org/10.1080/14756366.2019.1637861.
• Hassanzadeh F, Jafari E, Shojaei F, Sadeghi-Aliabadi H. Synthesis and cytotoxic activity evaluation of some new 1,3,4- oxadiazole, 1,3,4-thiadiazole and 1,2,4-triazole derivatives attached to phthalimide. Res Pharm Sci. 2021, 16 (6): 634- 642. https://doi.org/10.4103/1735-5362.327509.
• Hassanzadeh F, Jafari E, Zarei S, Sadeghi-aliabadi H. Synthesis, cytotoxic effect assessment and molecular docking studies of disubstituted thiadiazole ıncluding oxadiazole as hybrid component. Hacettepe Univ J Fac Pharm. 2022 ;42(4): 228-237. https://doi.org/10.52794/hujpharm.1069664.
• Karaburun AÇ, Acar Çevik U, Osmaniye D, Sağlık BN, Kaya Çavuşoğlu B, Levent S, Özkay Y, Koparal AS, Behçet M, Kaplancıklı ZA. Synthesis and evaluation of new 1, 3, 4-thiadiazole derivatives as potent antifungal agents. Molecules. 2018; 23 (12): 5-18. https://doi.org/10.3390/molecules23123129.
• Nasab RR, Mansourian M, Hassanzadeh F. Synthesis, antimicrobial evaluation and docking studies of some novel quinazolinone Schiff base derivatives. Res Pharm Sci. 2018; 13(3): 213-221. https://doi.org/10.4103/1735- 5362.228942.
• Akbari V, Safaiee F, Yegdaneh A. Bioassay-guided fractionation and antimicrobial activities of Padina australis extracts. Jundishapur J Nat Pharm Prod. 2020; 15(4): 1-6 . https://doi.org/10.5812/jjnpp.68304.
• Hassanzadeh F, Jafari E, Zarabi M, Khodarahmi G, Vaseghi G. Synthesis, cytotoxic evaluation, and molecular docking studies of some new 1,3,4-oxadiazole-based compounds. Res Pharm Sci. 2020; 15 (5): 454- 462. https://doi.org/10.4103/1735-5362.297848.